LOGIN  |  REGISTER
Chimerix

Certara to Participate in Upcoming Investor Conferences

May 03, 2022 | Last Trade: US$16.73 0.20 1.21

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences:

  • Bank of America 2022 Healthcare Conference
    Date and Time: Tuesday, May 10 at 3:00 p.m. ET
  • Citi’s Biopharma Virtual Co-Panel Day
    Date and Time: Wednesday, May 18 at 10:00 a.m. ET
  • Jefferies Healthcare Conference
    Date and Time: Wednesday, June 8 – Friday, June 10
    Details to be posted to the Company’s IR website
  • William Blair 42nd Annual Growth Stock Conference
    Date and Time: Thursday, June 9 at 10:20 a.m. ET

Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About Certara

Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Contact:
Daniel Yunger
Kekst CNC
This email address is being protected from spambots. You need JavaScript enabled to view it.

Astria Therapeutics

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Surmodics

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB